← Leaderboards
Vladimir S. Spiegelman
Pennsylvania State Univ Hershey Med Ctr
$6,129,643
Attributed
$7,162,321
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,162,321 · 6
By mechanism
R01$6,798,625 · 5
R21$363,696 · 1
Top collaborators
- Serge Y Fuchs2 shared
- Hong-Gang Wang1 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Anthony E Pegg$10,482,714
- William P Miller$64,934
- Michael D. Dennis$5,943,850
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayRna-Binding ProteinsRegulationMessenger RnaGenesBiologyCellsMalignant NeoplasmsResponseSignal PathwayGene ExpressionIn VivoPathway InteractionsCessation Of LifeSignal TransductionMediatingC-Myc GenesProteinsAmerican Cancer SocietyDesignPreventionInsightPathogenesisCancer Cell
Grant awards (22)
Targeting extracellular vesicles in neuroblastoma$690,013
R01 · FY2025 · CA · contact PI
Targeting Ã-TrCP regulators to improve CRC response to chemotherapy$673,747
R01 · FY2025 · CA · contact PI
Targeting Ã-TrCP regulators to improve CRC response to chemotherapy$701,596
R01 · FY2024 · CA · contact PI
Role and mechanisms of IGF2BP1 in melanoma pathogenesis$344,050
R01 · FY2024 · CA · contact PI
Role and mechanisms of IGF2BP1 in melanoma pathogenesis$354,914
R01 · FY2023 · CA · contact PI
Role and mechanisms of IGF2BP1 in melanoma pathogenesis$354,914
R01 · FY2022 · CA · contact PI
Role and mechanisms of IGF2BP1 in melanoma pathogenesis$362,157
R01 · FY2021 · CA · contact PI
Role and mechanisms of IGF2BP1 in melanoma pathogenesis$362,157
R01 · FY2020 · CA · contact PI
RNA-binding protein CRD-BP in melanocyte biology$319,028
R01 · FY2017 · AR · contact PI
RNA-binding protein CRD-BP in melanocyte biology$319,401
R01 · FY2016 · AR · contact PI
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis$156,893
R21 · FY2016 · CA · contact PI
RNA-binding protein CRD-BP in melanocyte biology$255,775
R01 · FY2015 · AR · contact PI
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis$170,128
R21 · FY2015 · CA · contact PI
RNA-binding protein CRD-BP in melanocyte biology$63,128
R01 · FY2015 · AR · contact PI
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesis$36,675
R21 · FY2015 · CA · contact PI
RNA-binding protein CRD-BP in melanocyte biology$316,379
R01 · FY2014 · AR · contact PI
RNA-binding protein CRD-BP in melanocyte biology$316,379
R01 · FY2013 · AR · contact PI
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers$268,149
R01 · FY2011 · CA · contact PI
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers$276,442
R01 · FY2010 · CA · contact PI
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers$276,442
R01 · FY2009 · CA · contact PI
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers$276,442
R01 · FY2008 · CA · contact PI
The Role of CRD-BP-regulated mRNA Stability in Colorectal Cancers$267,512
R01 · FY2007 · CA · contact PI